Satellite Symposium: Working towards precision medicine approaches for CLL

Raúl Córdoba, Alessandra Tedeschi, Xose Antón Suárez Puente

Overview of current approaches for the management of patients with chronic lymphocytic leukemia (CLL) presented at the 7th ESH Translational Research Conference on Lymphoid Malignancies.

The Satellite Symposium, titled ‘Working towards precision medicine approaches for CLL’, provided insights into current therapeutic options for patients with chronic lymphocytic leukemia (CLL), including continuous vs fixed-duration treatments with targeted therapies such as BTK inhibitors (BTKi). The experts discussed how patient and disease characteristics, such as the genetic profile (e.g., del(17p), _S)q, EvWL), inform treatment selection and sequencing. An overview of molecular mapping of CLL and its impact on outcome were also presented.

Download the Slide-Kit &bSb.

BWd1evm

OZút Hó6/gKu

F|+qqVBb1V YM$Myh?S

CaYf 33Uó3 F~án@O ~Zg,jg

Please login or register for full access

Register

Already registered?  Login